• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 8 of 38
Structural images of the main COVID-19 virus variants from Alpha to Omicron.
Health
BioNTech and London A.I. firm create ‘early warning system’ to spot dangerous new COVID-19 variants before they spread
By Jeremy KahnJanuary 12, 2022
A health care worker comforts a COVID-19 patient in Houston.
Health
We were promised Pfizer pills. Where are the other COVID treatments?
By Nicole GoodkindJanuary 11, 2022
A man receives a fourth dose of COVID-19 vaccine at Sheba Medical Center in central Israeli city of Ramat Gan on Dec. 31, 2021.
Health
Pushback grows against fourth COVID vaccine doses, with experts urging caution over expanding booster campaigns
By David MeyerJanuary 11, 2022
Pfizer is testing a hybrid COVID vaccine, mixing its original with a new formulation that shields against Omicron
Health
Pfizer is testing a hybrid COVID vaccine, mixing its original with a new formulation that shields against Omicron
By Riley Griffin and BloombergJanuary 10, 2022
With Omicron dominant, new COVID cases are up 254%—and those are just the reported ones
Health
With Omicron dominant, new COVID cases are up 254%—and those are just the reported ones
By Erika Fry and Nicolas RappJanuary 5, 2022
CDC panel approves booster shots for young teens
Health
CDC panel approves Pfizer boosters for younger teens
By Lauran Neergaard, Mike Stobbe and The Associated PressJanuary 5, 2022
Pfizer booster eligibility
Health
FDA clears Pfizer boosters for 12-to-15 year-olds
By Lauran Neergaard and The Associated PressJanuary 3, 2022
Photo illustration of a syringe jabbing a stock chart that shows shares rising and then falling
Finance
Omicron is upping booster jab demand. So why are COVID vaccine makers’ shares tanking?
By Jeremy KahnDecember 29, 2021
A health care worker prepares a Moderna booster vaccine dose.
Health
Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
By David MeyerDecember 27, 2021
Merck covid 19 pill
Health
FDA authorizes Merck COVID pill a day after approving Pfizer’s
By Matthew Perrone and The Associated PressDecember 23, 2021
Pfizer logo pill
Health
Pfizer pill becomes first FDA-approved home COVID treatment
By Matthew Perrone and The Associated PressDecember 22, 2021
COVID-19 vaccine in front of Israeli flag
Health
Israel to give fourth COVID vaccine doses to combat Omicron, despite lack of data on second boosters
By David MeyerDecember 22, 2021
COVID-19 pill
Health
FDA set to authorize Pfizer and Merck COVID pills this week
By Josh Wingrove, Jennifer Jacobs, Robert Langreth and BloombergDecember 21, 2021
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
Health
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
By Christiaan HetznerDecember 20, 2021
Europe taps Pfizer and BioNTech to provide 180 million more vaccines to face ‘ferocious’ Omicron threat
Health
Europe taps Pfizer and BioNTech to provide 180 million more vaccines to face ‘ferocious’ Omicron threat
By Christiaan HetznerDecember 17, 2021
1...
  • 6
  • 7
  • 8
  • 9
  • 10
...38
Most Popular
Success
A dropout living in a trailer, he got $1 million from Peter Thiel at 19—now he's a billionaire who says the American Dream isn't deadplaceholder alt text
By Orianna Rosa RoyleAugust 18, 2026
Personal Finance
Current price of oil as of August 18, 2026placeholder alt text
By Joseph HostetlerAugust 18, 2026
Personal Finance
With the national debt nearing $40 trillion, Bank of America has a warning for bond investorsplaceholder alt text
By Joshua HongAugust 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.